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Abstract. Bovine respiratory disease complex (BRDC) is one of the most significant diseases of cattle. Bacterial pathogens
involved in BRDC include Mannheimia haemolytica, Mycoplasma bovis, Histophilus somni, and Pasteurella multocida. We
developed and evaluated a multiplexed real-time hydrolysis probe (rtPCR) assay using block-based Peltier and rotary-based
thermocycling on lung tissue, nasal swabs, and deep nasopharyngeal swabs. The rtPCR results were compared to culture
or a gel-based M. bovis PCR using statistical analysis to determine optimum quantification cycle (Cq) cutoffs to maximize
agreement. The limits of detection were 1.2–12 CFU/reaction for each pathogen. M. haemolytica was the most prevalent
organism detected by rtPCR, and was most frequently found with P. multocida. The rtPCR assay enabled enhanced levels of
detection over culture for all pathogens on both thermocycling platforms. The rotary-based thermocycler had significantly
lower Cq cutoffs (35.2 vs. 39.7), which maximized agreement with gold standard culture or gel-based PCR results following
receiver operating characteristic analysis to maximize sensitivity (Se) and specificity (Sp). However, overall assay Se and Sp
were similar on both platforms (80.5% Se, 88.8% Sp vs. 80.1% Se, 88.3% Sp). Implementation of these tests could enhance
the detection of these pathogens, and with high-throughput workflows could reduce assay time and provide more rapid results.
The assays may be especially valuable in identifying coinfections, given that many more antemortem samples tested in our
study were positive for 2 or more pathogens by rtPCR (n = 125) than were detected using culture alone (n = 25).
Key words: Bacterial pathogens; bovine respiratory disease; clinical specimens; real-time PCR; receiver operating
characteristic analysis.

Introduction
Bovine respiratory disease complex (BRDC) is the most significant disease in beef cattle production, which in 2011 was
worth an estimated retail value of $79 billion in the United
States. BRDC is estimated to cost producers more than $13
per animal, making the economic impact to cattle production
tremendous.24 The total overall cost to the United States is
estimated to be >$1 billion as a result of production losses,
death, labor, and drug costs.7,9 Although effective antimicrobials and vaccines for BRDC have been licensed and are
available, the incidence of BRDC in feedlot cattle remains
high, with 62–72% of animals having lung lesions at slaughter indicative of prior BRDC, and with 61–68% of these
never having been treated.23,25 This tremendous cost and high
incidence of undiagnosed disease underscores the need for
new rapid and accurate tools to mitigate the impact of BRDC
on beef cattle production and enable targeted prevention and
treatment strategies.

Multiple pathogens, including both viruses and bacteria,
contribute to BRDC. The complex is frequently initiated by
infection with a virus that is subsequently exacerbated by
stress from transport and commingling. Such stress disrupts
local defenses and causes immune suppression, which enables
bacteria that are normal nasopharyngeal commensals to colonize deeper respiratory tissues, replicate, and secrete toxins in
lower airways causing tissue destruction, inflammation, and
pneumonia.18 Bacterial pathogens that are isolated frequently
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in association with BRDC include: Mannheimia haemolytica,
Pasteurella multocida, Histophilus somni, and Mycoplasma
bovis. A 2014 study investigating a large number of BRDC
mortalities in North American bovine feedlots showed M.
haemolytica to be the most frequently isolated (91%), followed by M. bovis (63%), H. somni (57%), and P. multocida
(13%).12 This supports other studies showing frequent isolation or detection of these agents in North American feedlots.2,12 Identification of the pathogens responsible for BRDC
is critical to development of effective prevention and treatment strategies, because some therapies, such as beta-lactam
antimicrobials, are ineffective against M. bovis, and several of
the pathogens have shown in vitro resistance to available antimicrobial therapies.16,21
Classically, bacterial pathogens of BRDC are identified
by isolation of that pathogen from lungs that have gross or
histologic lesions consistent with BRDC. However, tissues
or clinical specimens from diagnostic submissions are frequently from animals that have been treated with antimicrobials prior to submission and/or are chronic lesions. Many
specimens have undergone autolysis and have bacterial overgrowth or environmental contamination from field postmortem collection before receipt at a diagnostic laboratory. Some
specimens have undergone temperature extremes during
shipping that may impede the ability to isolate pathogens in
culture. A 2014 study has demonstrated that gel-based PCR
methodology was able to enhance the detection of bacterial
pathogens in pneumonic lung tissues by ~20%, indicating
that the potential for a large number of false-negative tests
exists when relying on culture alone.1 Frequently, only the
predominant organism is found given the overgrowth of a
single agent; therefore PCR has been explored as a tool to
identify potential coinfections in lung tissues.1
Real-time hydrolysis probe PCR (rtPCR) is a rapid tool
that enables the relative abundance of these organisms to be
calculated using quantification cycle (Cq) values, and thus
provide additional data to assist the clinician in determining
clinical relevance. Antemortem clinical samples, such as
nasal swabs (NS) and deep nasopharyngeal swabs (DNPS)
are frequently submitted to diagnostic laboratories for culture testing. The use of guarded swabs to sample deep nasopharyngeal passages has been shown to readily obtain M.
bovis and M. haemolytica, although swab isolates may not
always reflect those populations found in deeper tissues such
as lung.3,8
We determined the utility of a multiplex rtPCR assay to
detect bacterial pathogens of BRDC in clinical specimens
(NS, DNPS, and lung tissue) commonly submitted to diagnostic laboratories for testing. We performed receiver operating characteristic (ROC) analyses to determine the
quantification cycle (Cq) value as the optimal cutoff of a
multiplex rtPCR assay by maximizing its test accuracy (both
sensitivity [Se] and specificity [Sp] as the primary accuracy
indices) compared to gold standards. Additionally, we compared 2 rtPCR platforms, one that utilizes air heating and

cooling on a rotary-based design with high-power light-emitting diodes (RGQ; Rotor-Gene Q, Qiagen, Hilden, Germany)
with a traditional block-based Peltier heating and cooling
system (ABI; ABI 7500 Fast, Thermo Fisher Scientific,
Waltham, MA) to determine if the type of rtPCR instrumentation has an impact on results.

Materials and methods
Reference strains
Strains used for limit of detection analyses and preliminary
validation of the assays included: P. multocida (ATCC BAA1113), M. haemolytica (ATCC BAA-410), H. somni (129Pt),
and M. bovis (ATCC 25223; American Type Culture Collection, Manassas, VA). A collection of field isolates and off-target controls were also employed to ensure assay Sp (Table 1)
and included Mannheimia granulomatis, Mannheimia varigena, Mannheimia sp. Angen Group V, Bibersteinia trehalosi,
Gallibacterium anatis, and Gallibacterium sp. All isolates, if
not ATCC-sourced strains, were identified using matrixassisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS; Biotyper, Bruker Daltonics,
Billerica, MA) to the species level with scores of 2.0 or higher
and/or subjected to whole genome sequencing (Mannheimia
sp. Angen Group V, Mannheimia varigena). The M. haemolytica isolates represented all major genotypes and subtypes of
M. haemolytica as described previously, and were identified to
the species level using both MALDI-TOF MS and whole
genome sequencing.4,15

Isolation and identification of bacteria from
clinical specimens
Diagnostic specimens (NS, DNPS, and lung tissue) consisted
of submissions to the University of Nebraska–Lincoln Veterinary Diagnostic Center for bovine respiratory disease testing. Samples included NS (n = 43), lung tissues (n = 47),
and DNPS (n = 95). Although detailed clinical information
was not available for many submissions, most of these samples were most likely collected from non-healthy clinically
ill animals. Specimens were accessioned, processed, and
tested by trained personnel following validated and approved
standard operating procedures in an American Association of
Veterinary Laboratory Diagnosticians (AAVLD)-accredited
diagnostic laboratory. For bacterial culture, fresh lung tissues
were trimmed, dipped in alcohol, the exterior was flame sterilized, bisected, and the cut surface inoculated onto culture
media. Swabs were directly inoculated onto plates if submitted in a liquid medium, or suspended in a small volume of
phosphate-buffered saline (PBS). Culture media, including
tryptic soy agar with 5% sheep blood, chocolate agar, and
MacConkey agar (Remel, Lenexa, KS), were inoculated and
streaked for isolation. Samples were incubated in 5% CO2
and examined at 24 and 48 h after inoculation. Colonies with
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Table 1. Target and non-target isolates used to validate assay specificity for Mycoplasma bovis, Mannheimia haemolytica, Histophilus
somni, and Pasteurella multocida. Template cell lysate was prepared using a 1 McFarland standard of pure culture growth. Quantification
cycle (Cq) values for each target are reported using the Rotor-Gene Q instrument using threshold values of 0.1, except for red, which was
set to 0.25, and green, which was set to 0.15. Dynamic tube normalization was used for all analyses.
Cq value
Species/strain
M. bovis
UNL1
M. haemolytica
USMARC 28284
USMARC 28454
USMARC 28229
USMARC 34142
USMARC 33749
USMARC 23580
USMARC 23533
USMARC 23570
USMARC 23217
USMARC 23473
USMARC 22604
USMARC 39434
USMARC 33204
USMARC 23299
USMARC 23311
USMARC 23348
USMARC 28226
USMARC 23309
USMARC 33982
USMARC 34180
USMARC 1590
USMARC 1621
USMARC 1562
USMARC 32563
USMARC 32635
USMARC 33170
USMARC 23456
USMARC 32864
USMARC 1629
USMARC 22549
H. somni
ATCC43625
ATCC 700002
UNL22
UNL21
UNL20
UNL19
UNL18
UNL17
UNL16
P. multocida
UNL15
UNL14
UNL13
UNL12

M. bovis

M. haemolytica

H. somni

P. multocida

18.86

–

–

–

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–

20.02
19.1
20.06
19.30
19.14
19.19
18.73
19.16
18.53
23.22
16.81
17.26
19.2
23.06
20.61
20.56
25.99
19.73
23.54
18.40
17.92
20.08
22.24
24.86
21.14
22.44
19.63
20.69
20.55
20.23

–
–
–
–
–
–
–
–
–

–
–
–
–
–
–
–
–
–

16.79
17.97
13.41
13.13
22.86
22.98
26.61
14.34
21.75

–
–
–
–
–
–
–

–
–
–
–

–
–
–
–

–
–
–
–

10.07
13.73
13.37
12.65
(continued)
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Table 1. (continued)
Cq value

Species/strain
UNL11
UNL10
UNL9
UNL8
UNL7
UNL6
Mannheimia sp. Angen V
USMARC 28377
USMARC 23448
Mannheimia varigena
USMARC 33577
USMARC 23064
Mannheimia granulomatis
ATCC 49244
Actinobacillus pleuropneumoniae
ATCC 27050
Bibersteinia trehalosi
ATCC 29703
UNL5
UNL4
Gallibacterium anatis
UNL3
Gallibacterium sp.
UNL2

M. bovis

M. haemolytica

H. somni

P. multocida

–

–

–

–

–

–

–
–

–
–

–
–

15.02
10.90
11.95
17.40
15.44
16.62

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–
–

–

–

–

–

–

–

–

–

–
–
–

–
–
–

–
–
–

–
–
–

–

–

–

–

–

–

–

–

Dash (–) = no amplification detected (Cq of 0). Instrument source: Rotor-Gene Q, Qiagen, Hilden, Germany.

morphology consistent with M. haemolytica, P. multocida,
and/or H. somni were subjected to biochemical and/or other
phenotypic or MALDI-TOF MS testing validated for definitive identification of these organisms.

Nucleic acid extraction
For preliminary validations, nucleic acids were extracted
from reference strains in pure subculture growth by picking
several well-isolated colonies with a sterile stick and resuspending in 100 µL of nuclease-free water to a 1–2 McFarland standard turbidity. Cell suspensions were boiled at
100°C for 10 min to lyse bacterial cells. Cell debris was
clarified by centrifugation at 15,700 RCF for 2 min. Swab
samples were resuspended in 200 µL of nuclease-free water
and vortexed. One hundred µL of this eluent was transferred
to a sterile 2-mL microcentrifuge tube. Lung tissue was
placed in a filter Whirl-Pak (Nasco, Fort Atkinson, WI) with
1–5 mL of sterile PBS and placed in a stomacher for 30–
60 s. Once stomached, as much fluid as possible was taken
from the Whirl-Pak bag and placed in a 2-mL microcentrifuge tube. The tube was then spun at full speed (~13,500 ×
g) for 2 min. After centrifugation, 100 µL of the eluent was

transferred to a sterile 2-mL microcentrifuge tube. These
samples were then subjected to DNA extraction (QiaCube,
DNeasy blood and tissue kit, Qiagen).

M. bovis gel-based PCR
The presence or absence of M. bovis was categorized using
the previously validated PCR assay used currently in our
laboratory (Lauerman L, et al. Nucleic acid amplification
assays for diagnosis of animal diseases. Am Assoc Vet Lab
Diagnosticians Workshop; 1998; Minneapolis MN). The
assay included 25 µL of master mix, which contained
16.9 µL of nuclease-free water, 2.5 µL of 10× PCR Rxn
buffer, 2 µL of 50 mM MgCl2, 0.5 µL each of F primer
(100 mM) and R primer (100 mM), 0.5 µL of dNTPs (100
mM; Invitrogen, Carlsbad, CA), 0.1 µL of Taq DNA polymerase (Invitrogen), and 2 µL of template. The mix was then
subjected to the following thermocycling conditions: 95°C
for 3 min, followed by 45 cycles at 94°C for 40 s, 55°C for
30 s, and 72°C for 1.5 min, ending at 72°C for 5 min. PCR
products were analyzed using capillary gel electrophoresis
(QIAxcel, Qiagen) and compared to a reference isolate used
as a positive control.
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Table 2. Oligonucleotide sequences for primers and probes used in the assay. For Histophilus somni probe, JOE-labeled probe was
used in the ABI assay, and the Cy5.5-labeled probe was used for the RGQ assay.
Target/primer or probe
Mycoplasma bovis (oppD)
PMB996-F
PMB1066-R
Mbovis1016 (FAM/TAMRA)
Mannheimia haemolytica (LktD)
F
R
P (CY5/BHQ)
Histophilus somni (31kD)
F
R
P (JOE/BHQ)
P2 (Cy5.5/BHQ)
Pasteurella multocida (Pm1231)
F
R
P (Texas Red/BHQ)
Internal control
IC-1F
IC-2R
PNED/MGBNFQ
M. bovis
M. bovis-F
M. bovis-R

Sequence (5’–3)

Size

Reference

TCAAGGAACCCCACCAGAT
AGGCAAAGTCATTTCTAGGTGCAA
TGGCAAACTTACCTATCGGTGACCCT

71

22

CTGCAACAAAGCCGATATCTTT
TACGACTGCTGAAACCTTGAT
ACACATCGTCTTCCGGCACAATGA

95

Current study

GCAATGATGTACCWGCCAAAG
CCTTCAGCTCACCATTACCATA
TTGCTTACGTCCAAACCGTCGTGT
TTGCTTACGTCCAAACCGTCGTGT

111

Current study

ATCCCTGCGTTACAGAGTTTAG
GACGYGGGYAGTACCATAAA
TTGATGCCTTCTTTGCGGGTTTCG

110

Current study

GACCACTACCAGCAGAACAC
CTTGTACAGCTCGTCCATGC
AGCACCCAGTCCGCCCTGAGCA

177

11

TGATAGCAATATCATAGCGGC
GTAGCATCATTTCCTATGCTAC

*
415

ABI = ABI 7500 Fast, Thermo Fisher Scientific, Waltham, MA; RGQ = Rotor-Gene Q, Qiagen, Hilden, Germany.
*Lauerman L, et al. Nucleic acid amplification assays for diagnosis of animal diseases. Am Assoc Vet Lab Diagnosticians Workshop; 1998; Minneapolis MN.

Real-time PCR assay design
Primers and probes for the multiplex PCR assay were
designed using a previously described assay for M. bovis.22
Targets for M. haemolytica,6 P. multocida,14 and H. somni26
were selected from previously described gene targets found
to discriminate these organisms with additional reference
sequences found in GenBank (Supplementary Table 1). Gene
sequences from these targets were identified using BLASTn
(https://blast.ncbi.nlm.nih.gov/), aligned, and utilized for
primer design using PrimerQuest software with settings for a
probe-based assay design (Integrated DNA Technologies
[IDT], Iowa City, IA; Table 2). Primer sequences were evaluated in silico with reference sequences where available. The
sequences included 21 fully assembled genomes of P. multocida, 4 of which were from cattle (Supplementary Fig. 1), 9
fully assembled genomes of H. somni (Supplementary Fig.
2), 14 fully assembled genomes of M. haemolytica (Supplementary Fig. 3), and 9 fully assembled genomes of M. bovis
(Supplementary Fig. 4). Additionally, the lktD locus of 1,133
M. haemolytica isolates sequenced in a previous study was
used for screening of potential polymorphisms at the primerbinding sites.4
Primers and probe sequences were selected that were
unique and did not possess significant identity to other
sequences in GenBank, with the exception of M. haemolytica

(Table 2). M. haemolytica had some sequence identity with
closely related species; however, some polymorphisms were
present in primer and probe-binding sites for non-target species (Supplementary Fig. 5). All of the primers and probes
were synthesized and purchased from IDT, except minor
groove binder probes used for the internal control (Molecular
Probes, Thermo Fisher Scientific). These primers and probes
were combined with a heterologous internal control target
system11 (intype IC DNA, Qiagen) and run on a rotary realtime PCR instrument (hereafter RGQ; Rotor-Gene Q, Qiagen) in a single 5-plex reaction, or run on a block-based
Peltier real-time thermocycling system in a 4-plex reaction
without an internal control (hereafter ABI; ABI 7500 Fast,
Thermo Fisher Scientific).
The number of detection channels, requirements for passive reference dyes, light source, and temperature kinetics of
the 2 instruments varied; therefore, separate protocols were
used. Protocols were independently optimized for primer and
probe concentrations and annealing temperatures, and subsequently evaluated utilizing different instruments. For ABI,
the 25-µL PCR master mix contained 6.1 μL of nucleasefree H2O, 12.5 μL of 2× Quantifast multiplex PCR master
mix (Qiagen), 0.4 μL of 50× ROX solution, 1 µL of each
primer–probe mix (4 total µL) containing F (10 μM), R
(10 μM), and P (10 μM), and 2.0 µL of template DNA. For
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RGQ, the 25-µL PCR master mix contained 10 μL of 2×
Quantifast multiplex PCR master mix (Qiagen), 1.0 μL of
each primer–probe mix (5 μL total) containing F (10 μM),
R (10 μM), and P (10 μM), and 5.0 µL of template DNA.
The PCR reactions were subjected to thermocycling under
the following conditions: 95°C for 5 min, then 45 cycles of
95°C for 15 s, 60°C for 45 s. Cq was established by subtracting 10% from the peak fluorescence intensity of the positive
control for ABI. This was set manually by adjusting the baseline up to the peak fluorescence of the positive control curve
and then taking 10% of that value, resulting in a Cq of 0.01–
0.1. The Cq threshold for the RGQ was set at a fixed value of
0.1 for all detection channels, except crimson, which was set
at 0.05 in clinical samples. For undiluted DNA extracted
from pure culture, thresholds were set at threshold values of
0.1, except for red, which was set to 0.25, and green, which
was set to 0.15. Dynamic tube normalization was used for all
analyses on RGQ.

Preliminary assay validation and analytical Se
The multiplex PCR assays were initially validated using
ATCC control organisms and reference bacterial isolates.
Target and off-target validation controls were run in undiluted clarified cell lysate suspension in single reaction on the
RGQ platform (Table 1). For analytical Se, ATCC reference
isolates were used to generate standards and run on both
instruments. Briefly, sterile brain–heart infusion (BHI) broth
(P. multocida and M. haemolytica; Oxoid, Hants, UK), BHI
supplemented with 0.5% yeast extract and 0.05% thiamine
monophosphate (H. somni), and mycoplasma broth (M.
bovis; Udder Health Systems, Meridian, ID) was inoculated
with several isolated colonies of fresh growth and shaken at
200 rpm for ~4 h at 37°C at a 1:10 flask-to-media ratio under
atmospheric conditions (P. multocida and M. haemolytica) or
incubated in 5% CO2 without shaking (H. somni and M.
bovis). Cultures of M. bovis were incubated for ~24 h. Optical density from cultures was measured and adjusted to ~0.26
absorbance (OD600) using a spectrophotometer (UV GENESYS 140, Thermo Fisher Scientific). Cultures were serially
diluted in 10-fold dilutions in sterile PBS and plated onto
trypticase soy agar with 5% sheep blood (P. multocida and
M. haemolytica), chocolate agar (H. somni; Remel), or
mycoplasma agar (M. bovis; Udder Health Systems) incubated at 37°C in 5% CO2. Colonies enumerated and colonyforming units (CFU)/mL were calculated. Remaining
dilutions were immediately placed on ice, and nucleic acid
was extracted as described above.

Statistical analysis
Statistical analyses were conducted to 1) determine the optimal thresholds for the detection of H. somni, M. haemolytica,
and P. multocida, for RGQ and ABI rtPCR assays compared
to culture or gel-based PCR (M. bovis) as gold standards,
respectively, and 2) to evaluate the concordance between

RGQ and ABI assays. Analyses were performed using either
all data or data stratified by pathogens and sample matrices.
All statistical analyses were performed in R v.3.2.3 (https://
www.r-project.org/).

Threshold determination
ROC curves were plotted to determine pathogen-detection
thresholds, by using the pROC package in R.20 ROC curve is
a plot of the true-positive rate (Se) against the false-positive
rate (1 − Sp) for a series of possible cut-points of a test by
comparison to the gold standards, which facilitated setting
the optimal thresholds for the tests by balancing the tradeoff
of test Se and Sp. For M. haemolytica, P. multocida, and H.
somni, culture isolation and identification were used as the
gold standard. For M. bovis, the gel-based PCR approach
was used in lieu of culture as a gold standard, because this
was the validated standard approach to M. bovis detection
used in our laboratory.
The Cq value of “0” for RGQ and ABI rtPCR assays was
replaced by “50” in the whole dataset, which was larger than
the largest observed Cq value in the dataset. A rtPCR result
of “0” indicated the absence of DNA products, which should
be referred to as a negative result. However, the calculations
in the roc() function assumed a Cq value equal to or smaller
than a cut-point referred to a positive result. With this
assumption, a PCR result of “0” would be referred to as a
positive detection. Changing zeros to a value greater than the
largest Cq value in the whole dataset guaranteed a consistent
analysis that accurately reflected the PCR results.
Specificity and Se values of the optimal thresholds were
computed and presented as percentages. The 95% confidence
intervals (CI) of the Se and Sp values were computed with
2,000 stratified bootstrap replicates using the ci.thresholds()
function in the {pROC} package. ROC curves were plotted
with the indication of the Se (%) and Sp (%) of computed
optimal thresholds.

Concordance analysis
Performance of RGQ and ABI rtPCR assays were evaluated
by comparing the difference in the mean Cq values of both
assays by ANOVA and Cohen kappa statistic.5 A p ⩽ 0.05
was considered statistically significant.
Linear regression models were developed using the
“lm()” function to compare RGQ and ABI real-time Cq values using ANOVA. The equations included “organism” and/
or “source” variables as potential modifiers on the association between Cq values obtained by RGQ and ABI assays,
which were all categorical data with more than 2 mutually
exclusive categories. For example, the factor “organism”,
contained 4 categories of “H. somni”, “M. haemolytica”,
“M. bovis”, and “P. multocida”. A dummy coding approach
was used to develop the linear regression models to estimate
the impact of effect modifiers on the association of interest.
To dummy code the k categories, where k denotes the num-
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Table 3. Sensitivity and limit of detection in colony-forming units per reaction (CFU/rxn) for both assays using characterized
reference strains of each isolate. Limit of detection utilized reference strains Pasteurella multocida (ATCC BAA-1113), Mannheimia
haemolytica (ATCC BAA-410), Histophilus somni (129Pt), and Mycoplasma bovis (ATCC 25223).
Cq
Organism
M. haemolytica

P. multocida

H. somni

M. bovis

CFU/rxn
2,400
240
24
2.4
1,200
120
12
1.2
1,200
120
12
1.2
1,200
120
12
1.2

RBQ

ABI

RGQ

28.2
31.69
33.96
–
30.46
34.21
36.38
–
30.60
33.06
36.26
–
30.12
33.67
37.4
–

27.4
31.38
34.43
37.67
26.08
29.05
31.72
–
28.02
30.49
35.05
37.6
25.98
29.97
33.31
36.34

ABI

R2

RE

R2

RE

0.998

1.01

0.998

0.996

0.999

1.00

0.993

0.97

0.999

1.02

0.993

1.06

0.998

0.95

0.997

0.91

ABI = ABI 7500 Fast, Thermo Fisher Scientific; Cq = quantification cycle; dash (–) = no amplification detected; RE = reaction efficiency (10^(–1/m) – 1); RGQ = Rotor-Gene
Q, Qiagen.

ber of levels of a specific factor (for example regarding the
“organism”, k = 4), k – 1 dummy variables needed to be
constructed (Di, i = 1, …, k – 1, where Di denoted dummy
variables for a specific factor), with Di set to 1 if a case was
in category i, otherwise to 0.10 Regarding the factor “organism” for example, dummy variables of “M. haemolytica”,
“M. bovis”, and “P. multocida” were constructed, which
means “H. somni” was set as the reference category. Hence,
pathogen dummy variables (“M. haemolytica”, “M. bovis”,
and “P. multocida”) are all set to “0” for cases in the category of “H. somni”. In the case of M. haemolytica–associated test results, the pathogen dummy variable setting was
“M. haemolytica” = 1, “M. bovis” = 0 and “P. multocida”
= 0. The same approach was applied to variable “source”.
The comparison was done by “Anova” function in the
“{car}” package. For example, ABI results were the
response values in the linear regression model for the dataset containing all of the information for the sample source
“lung tissue”, where RGQ results and organism type were
the explanatory variables. ANOVA calculated a p value
determining the significance of the coefficient for the RGQ
test results, where p ⩽ 0.05 indicated a significant association between the Cq values of RGQ and ABI. For ANOVA,
Cq values of “0” were kept as they were, and the equations
showing the significant relationship between ABI and RGQ
values for each dataset were included in the results.
Cohen kappa statistic was used to explore the concordance between RGQ and ABI results, as well as the comparisons of RGQ and ABI (at their optimal thresholds) with

the gold standard results, respectively. Cq values of “50”
were used to replace “0” for the same aforementioned reason. The following categories were assigned for the agreement associated with kappa statistic: <0 indicating no
agreement, 0–0.20 slight, 0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 substantial, and 0.81–1 almost perfect agreement.13 The “kappa2” function in the {“irr”} package was
used for the calculations.10

Results
Analysis performed in silico demonstrated that all primer
sequences used for the assay had 100% identity to all reference sequences isolated from the target species (bovine).
Preliminary validation of test Sp demonstrated no amplification of non-target species (Cq of 0) for each non-target reference culture isolate tested (Table 1). However, in silico
analysis indicated that closely related species, such as
Mannheimia glucosida and Mannheimia ruminalis, have
high sequence identity with target sequences, where in some
cases only a single polymorphism was present in the primer–
probe sequences (Supplementary Fig. 5).
The assay limits of detection were calculated using reference bacterial isolates (Table 3). The assays were characterized as having limits of detection and corresponding Cq
values for M. haemolytica as 24 CFU/reaction (ABI Cq 33.9)
or 2.4 CFU/reaction (RGQ Cq 37.6); for P. multocida 12
CFU/reaction (ABI Cq 36.3) or 1.2 CFU/reaction (RGQ Cq
31.7); for H. somni 12 CFU/reaction (ABI Cq 34.7) or 1.2
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Table 4. Frequency of coinfections across all sample types. PCR results were categorized as positive if pathogen was detected in ⩽40
quantification cycles on either instrument.
M. haemolytica

Mannheimia haemolytica
Pasteurella multocida
Histophilus somni
Mycoplasma bovis

P. multocida

H. somni

M. bovis

PCR

Culture

PCR

Culture

PCR

Culture

PCR

Conv PCR

(136)
x
x
x

(63)
x
x
x

98
(119)
x
x

27
(88)
x
x

38
36
(48)
x

1
6
(14)
x

27
24
20
(54)

7
7
6
(23)

Conv PCR = conventional PCR; x = 185 total samples. Numbers in parentheses are the total number of positives detected.

CFU/reaction (RGQ Cq 37.6); and for M. bovis 12 CFU/
reaction (ABI Cq 37.4) or 1.2 CFU/reaction (RGQ Cq 36.3).
The most prevalent finding in diagnostic specimens using
the culture or gel-based PCR approach was P. multocida (n
= 88), followed by M. haemolytica (n = 63), M. bovis (n =
23), and H. somni (n = 14; Table 4). When classified according to rtPCR results only, levels of detection increased, with
M. haemolytica the most prevalent (n = 136), followed by P.
multocida (n = 119), M. bovis (n = 54), and H. somni (n =
48; Table 4). Co-detections were frequently found (Table 4),
with the most frequent combination being M. haemolytica
and P. multocida (n = 98). Thus, compared to rtPCR, gold
standard testing detected 29%, 43%, 46%, and 74% of H.
somni, M. bovis, M. haemolytica, and P. multocida positive
samples, respectively.
When examining co-detections based on sample type, the
number of lung tissues that were positive for 2 or more
pathogens using the least stringent criterion (RGQ platform
with a Cq value of ⩽ 40) was 26. This was an additional 8
co-detections over the 18 using culture and gel-based PCR.
For antemortem samples, there were 125 specimens with 2
or more pathogens detected, which was much more than the
25 co-detections that were found with culture and gel-based
PCR. Much of this enhanced detection may have been the
result of detection of non-viable organisms that could not be
isolated using the culture approach. However, one exception
was H. somni, in which case 4 lung samples were positive by
culture, but negative by rtPCR on both platforms (Supplementary Table 3). These isolates were subsequently re-grown
in pure culture; the lysates were tested using both PCR platforms, and were positive with comparable Cq values to other
H. somni run in pure culture.
Other discrepant results with negative rtPCR and positive
culture results were one M. haemolytica isolate from a NS
and a DNPS, a P. multocida isolated from a lung, and 3 from
DNPS that were cultured but not detected by either PCR
assay (Supplementary Table 3). These isolates were lost to
follow-up, so they could not be further evaluated by testing
isolates. However, discrepant results may be the result of
misclassification of the organism from the initial isolate
identification, primer–probe mismatch with the isolate, or
extraction errors.

Cq cutoff values were calculated to maximize agreement
between culture results (gold standard test) and rtPCR results
using ROC analysis. Values ranged from a minimum of 29.8
for M. haemolytica in lung matrices using the RGQ assay to
a maximum of 44.9 for P. multocida in NS matrices run on
the ABI (Supplementary Table 2). Pathogen-specific cutoff
Cq values across matrices ranged from a low of 33.4 for M.
haemolytica on the ABI to 44.9 for P. multocida on the ABI
(Supplementary Table 2). Overall Cq values for all assays
were significantly lower (p ⩽ 0.05) on the RGQ (35.2) than
the ABI (39.7), indicating a significantly lower detection
limit threshold of the RGQ, in general. As the ROC-based Cq
values were calculated by maximizing agreement of rtPCR
tests and the gold standard culture tests, the values are not
indicative of the analytical cutoffs of CFU numbers beyond
which quantitative results from rtPCR are valid. Instead, the
Cq values refer to cutoffs that would need to be applied to
enable the rtPCR methods to produce a result similar to the
gold standard from both Se and Sp perspectives, and were
calculated for comparative purposes.
ROC analysis of the 4 pathogens across all 3 sample types
demonstrated very similar levels of Se and Sp between the 2
instruments compared to the gold standard (Fig. 1; represented by overall equations of ABI = 0.27 + 0.46 × RGQ +
2.49 × M. bovis + 5.37 × M. haemolytica + 7.17 × P. multocida – 3.33 × lung − 0.83 × nasal), where ABI and RGQ
represented the Cq values measured by these 2 types of
instruments; M. bovis, M. haemolytica, and P. multocida
were the dummy variables for pathogen types; and lung and
nasal were the dummy variables for sample matrices. This
equation could be used to quantify the association between
Cq values measured by ABI and RGQ. For example, to
examine the association between M. haemolytica in lung tissues, the pathogen dummy variables were set as “M. haemolytica” = 1, “P. multocida” = 0, and “M. bovis” = 0, and
matrices dummy variables were set as “Lung” = 1 and
“Nasal” = 0. This resulted in ABI = 2.31 + 0.46 × RGQ.
The agreement between instruments on each assay was
also very high, with substantial to almost perfect agreement
for all pathogens and matrices by kappa statistic for interinstrument agreement (⩾0.784), except for H. somni (Supplementary Table 2). For H. somni in lung and DNPS
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Figure 1. Receiver operating characteristic curves depicting
the concordance between the ABI and RGQ real-time PCR (rtPCR)
assays based on a crude comparison regardless of pathogens and
sample types. The rtPCR assays evaluated were the block-based
Peltier real-time thermocycling system (ABI 7500 Fast, Thermo
Fisher Scientific) and the rotary real-time PCR instrument (RotorGene Q, Qiagen). The gray diagonal line represents agreement
between assays no better than chance alone. The gray solid and
black dashed lines are the observed ROC curves for RGQ and
ABI assays, respectively. The gray circle and black solid circle
(arrow) have the greatest perpendicular distances from the diagonal
line, suggesting the optimal quantification cycle values with the
sensitivities and specificities of the RGQ and ABI rtPCR assays for
pathogen detection.

matrices, agreement was only moderate (0.619 and 0.54,
respectively). Additionally, for all pathogens except H.
somni, agreement with lung tissue gold standard testing was
highest, and had substantial or nearly perfect agreement with
gold standard testing. DNPS also provided mostly moderate
levels of agreement (0.525–0.664) with gold standard testing
for pathogens, except for H. somni, which had substantial
levels of agreement with gold standard testing for both assays
(0.694 and 0.789). Nasal swab matrices had the lowest overall agreement with gold standard testing, with fair-to-moderate levels of agreement (0.353–0.525).

Discussion
In our study, the culture-based result for M. haemolytica, H.
somni, and P. multocida, or gel-based PCR result for M.
bovis, was considered the gold standard, and both gave a
dichotomous outcome of positive or negative for the target
pathogen. The rtPCR assay produced a continuous outcome
(i.e., the Cq value), which allowed flexibility to design the
assay for multiple purposes by varying the Cq cutoff to transfer the continuous outcome into an answer of positive or
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negative. For example, the optimal cutoff value of Cq of the
multiplex rtPCR approach in our study was determined by
trading off Se and Sp using ROC to maximize the similarity
of results produced by the multiplex rtPCR assay and the
gold standard. Because the rtPCR is much more sensitive
than the gold standard for detecting these bacterial species,
the Se and Sp for rtPCR look low. Therefore, it may not
always be reasonable to compare the superiority of a PCR
assay over the gold standard based on the Se and Sp values
determined by our approach.
If the purpose was to design a “rule-out” test with a high
Se to detect a pathogen, a higher Cq cutoff could be used.
When a cutoff of 40 was used for M. haemolytica in DNPS,
the multiplex rtPCR assay had fewer false-negatives compared to the gold standard. As a result, a very high Se of
97.4% was found for the new test (vs 74% based on the optimal cutoff), which indicates that a true infection can be
detected at a probability of 97.4%, although it is compromised by a lower Sp of 41% (vs 78% based on the optimal
cutoff). This is the ideal property of a test to rule out the
presence of the infection by a particular pathogen when a
negative result is observed. Conversely, lower cutoffs would
be more likely to identify infections with a particular pathogen of interest; in other words, higher Sp giving a better
“rule-in” test with a compromise of lower Se. Given that
BRDC is comprised of multiple opportunistic pathogens that
may exist in normal animals at various levels, especially in
antemortem clinical samples, interpretation of testing results
is complex, and therefore multiple strategies were used to
assess the rtPCR test and to compare results to traditional
detection techniques. The Cq cutoff applied should reflect
the goals of the test, and could be applied to either a “rule-in”
or a “rule-out” diagnostic approach. Further clinical trials
could also be conducted to relate shedding of BRD pathogens in antemortem samples to find Cq cutoffs that maximize agreement with clinical signs and/or the presence of
postmortem lesions.
In general, lung tissues had higher agreement than other
samples with the culture or gel-based PCR, followed by
DNPS and NS. However, some discrepancies, such as those
found with H. somni, were attributed to sampling differences
between the tissue utilized for culture versus extracted for
PCR. H. somni infections may be more prone to this type of
sampling error, because the lung lesions can be more variable in distribution and type. Bovine respiratory disease
caused by H. somni is typically a bilateral lobar pneumonia
in the cranioventral lung; however, chronic infections may
induce necrotic foci that are distributed unevenly. Additionally, given that H. somni can cause septicemia, pneumonia
may also be interstitial, which may have significantly different pathogen distribution within tissues.17
Less agreement in DNPS and NS was likely the result of
contaminating environmental organisms that are typically
present in the upper respiratory tract, which can rapidly outgrow pathogens on culture plates and lead to false-negative
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culture results. Survival and subsequent recovery of these
organisms in swabs and in transport media can also be lower
when compared to tissues, leading to false-negative culture
results. Additionally, some of the pathogens, such as P. multocida, can grow rapidly and be very mucoid, making culture
assessment of mixed pathogen cultures challenging. Therefore, although the agreement was lowest in swab samples, the
PCR methodology may be most useful for these given the
potential for high false-negative culture rates in these specimen types. However, even though detection is enhanced
using a PCR-based approach, phenotypic testing of susceptibility would not be possible without an isolate, therefore culture is still required to guide antimicrobial therapy, and as
stated above, mere detection of these pathogens may not indicate clinical infection.
The RGQ yielded significantly lower Cq cutoffs that maximized agreement with gold standards over the ABI instrument,
in agreement with previous work.19 This is potentially because
the more precise temperature control and rapid temperature
adjustment enhanced overall PCR efficiency. Some differences
may be the result of how the Cq threshold values were applied;
however, the threshold levels used for the ABI were uniformly
lower, and thus would likely have lowered overall Cq compared to the RGQ. However, these differences in corresponding
Cq values did not affect the overall Se and Sp of the assays,
whereby the ABI and RGQ were nearly identical when the Cq
cutoff values that maximized these values were applied.
Detection of pathogens in samples with rtPCR, especially
in the absence of postmortem lesions, may not indicate the
presence of disease. For antemortem samples, further
research is needed to determine if a specific Cq cutoff used
to assess nasal shedding levels can be used to maximally predict a clinical infection, given that many of these agents colonize the upper respiratory tract in normal, clinically healthy
animals; stressed and sick cattle may have higher levels of
shedding, and thus lower Cq values. Currently, pathogen
burdens and shedding can be estimated based on the Cq
value and copy number, but how to best apply this information to clinical treatment is an area for further study, because
relevant clinical data that may allow for classification of
these specimens is unavailable. However, the samples tested
were from submissions from presumably non-healthy cattle,
and therefore may not be representative of normal healthy
animal populations. A multiplex hydrolysis probe rtPCR
assay when utilized in either an RGQ or ABI instrument
heavily increases the number of bovine respiratory pathogens that can be detected in NS, DNPS, and lung tissues over
culture and gel-based PCR assays. The utilization of highthroughput extraction methods in conjunction with this assay
would provide results in a matter of hours, rather than days,
over culture methodology. This would strongly enhance the
ability to detect pathogens in highly mixed specimens such
as NS and DNPS, enabling veterinarians and clinicians to
diagnose disease and administer treatment or implement prevention strategies more rapidly.
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